Wisse Van Os (Wisse van Os)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 14

Top Topics

Methicillin Resistant Staphylococcus Aureus

Cerebrospinal Fluid

Top Venues

The Journal of antimicrobial chemotherapy

Clinical and translational science

Antibiotics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Felix Bergmann, Michael Wölfl-Duchek, Anselm Jorda, Valentin Al Jalali, Amelie Leutzendorff, Maria Sanz-Codina, Daniela Gompelmann, Karin Trimmel, Maria Weber, Sabine Eberl, Wisse Van Os, Iris K Minichmayr, Birgit Reiter, Thomas Stimpfl, Marco Idzko, Markus Zeitlinger
Pharmacokinetics of isavuconazole at different target sites in healthy volunteers after single and multiple intravenous infusions. The Journal of antimicrobial chemotherapy 79 (5) (2024)
Wisse Van Os, Markus Zeitlinger
Target attainment of intravenous lefamulin for treatment of acute bacterial skin and skin structure infections. The Journal of antimicrobial chemotherapy 79 (2) (2024)
Felix Bergmann, Michael Wölfl-Duchek, Anselm Jorda, Valentin Al Jalali, Amelie Leutzendorff, Maria Sanz-Codina, Daniela Gompelmann, Karin Trimmel, Maria Weber, Sabine Eberl, Wisse Van Os, Iris K Minichmayr, Birgit Reiter, Thomas Stimpfl, Marco Idzko, Markus Zeitlinger
Pharmacokinetics of isavuconazole at different target sites in healthy volunteers after single and multiple intravenous infusions. The Journal of antimicrobial chemotherapy 79 (5) (2024)
Vincent Aranzana-Climent, Wisse Van Os, Amir Nutman, Jonathan Lellouche, Yael Dishon-Benattar, Nadya Rakovitsky, George L Daikos, Anna Skiada, Ioannis Pavleas, Emanuele Durante-Mangoni, Ursula Theuretzbacher, Mical Paul, Yehuda Carmeli, Lena E Friberg
Integration of individual preclinical and clinical anti-infective PKPD data to predict clinical study outcomes. Clinical and translational science 17 (7) (2024)
Wisse Van Os, Markus Zeitlinger
Target attainment of intravenous lefamulin for treatment of acute bacterial skin and skin structure infections. The Journal of antimicrobial chemotherapy 79 (2) (2024)
Vincent Aranzana-Climent, Wisse Van Os, Amir Nutman, Jonathan Lellouche, Yael Dishon-Benattar, Nadya Rakovitsky, George L Daikos, Anna Skiada, Ioannis Pavleas, Emanuele Durante-Mangoni, Ursula Theuretzbacher, Mical Paul, Yehuda Carmeli, Lena E Friberg
Integration of individual preclinical and clinical anti-infective PKPD data to predict clinical study outcomes. Clinical and translational science 17 (7) (2024)
Wisse Van Os, Markus Zeitlinger
Target attainment of intravenous lefamulin for treatment of acute bacterial skin and skin structure infections. The Journal of antimicrobial chemotherapy 79 (2) (2024)
Vincent Aranzana-Climent, Wisse Van Os, Amir Nutman, Jonathan Lellouche, Yael Dishon-Benattar, Nadya Rakovitsky, George L Daikos, Anna Skiada, Ioannis Pavleas, Emanuele Durante-Mangoni, Ursula Theuretzbacher, Mical Paul, Yehuda Carmeli, Lena E Friberg
Integration of individual preclinical and clinical anti-infective PKPD data to predict clinical study outcomes. Clinical and translational science 17 (7) (2024)
Felix Bergmann, Michael Wölfl-Duchek, Anselm Jorda, Valentin Al Jalali, Amelie Leutzendorff, Maria Sanz-Codina, Daniela Gompelmann, Karin Trimmel, Maria Weber, Sabine Eberl, Wisse Van Os, Iris K Minichmayr, Birgit Reiter, Thomas Stimpfl, Marco Idzko, Markus Zeitlinger
Pharmacokinetics of isavuconazole at different target sites in healthy volunteers after single and multiple intravenous infusions. The Journal of antimicrobial chemotherapy 79 (5) (2024)
Wisse Van Os, Markus Zeitlinger
Target attainment of intravenous lefamulin for treatment of acute bacterial skin and skin structure infections. The Journal of antimicrobial chemotherapy (2024)
Felix Bergmann, Michael Wölfl-Duchek, Anselm Jorda, Valentin Al Jalali, Amelie Leutzendorff, Maria Sanz-Codina, Daniela Gompelmann, Karin Trimmel, Maria Weber, Sabine Eberl, Wisse Van Os, Iris K Minichmayr, Birgit Reiter, Thomas Stimpfl, Marco Idzko, Markus Zeitlinger
Pharmacokinetics of isavuconazole at different target sites in healthy volunteers after single and multiple intravenous infusions. The Journal of antimicrobial chemotherapy (2024)
Wisse Van Os, Markus Zeitlinger, Anh Duc Pham, Gert-Jan Wijnant, Perrin Ngougni Pokem, Françoise Van Bambeke, Johan G C van Hasselt, Markus Zeitlinger
Pharmacokinetic/pharmacodynamic model-based optimization of temocillin dosing strategies for the treatment of systemic infections. The Journal of antimicrobial chemotherapy (2024)
Felix Bergmann, Michael Wölfl-Duchek, Anselm Jorda, Valentin Al Jalali, Amelie Leutzendorff, Maria Sanz-Codina, Daniela Gompelmann, Karin Trimmel, Maria Weber, Sabine Eberl, Wisse Van Os, Iris K Minichmayr, Birgit Reiter, Thomas Stimpfl, Marco Idzko, Markus Zeitlinger
Pharmacokinetics of isavuconazole at different target sites in healthy volunteers after single and multiple intravenous infusions. The Journal of antimicrobial chemotherapy 79 (5) (2024)
Wisse Van Os, Markus Zeitlinger
Predicting Antimicrobial Activity at the Target Site: Pharmacokinetic/Pharmacodynamic Indices versus Time-Kill Approaches. Antibiotics (Basel, Switzerland) 10 (12) (2021)